Here at Last: Treatment Options for VEXAS
We have known about the VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome for…
View Resource
New Biomarkers and Therapeutics Show Potential in Still's Disease
Adult-onset Still’s disease (AOSD) is a rare complex, sporadic, systemic autoinflammatory disease similar to…
View Resource
Anakinra Effective in Systemic JIA, Irrespective of HLA-DRB1 and IL1RN Variants
A prospective study of first line use anakinra in systemic juvenile idiopathic arthritis (sJIA) proved…
View Resource
JAK Inhibitors in Difficult Still’s Disease
A small retrospective study suggests that patients with difficult to treat adult-onset Still’s disease…
View Resource
QD197 – Still’s (or Not) NEJM CPC https://youtu.be/_xnCaxeqidwQD198 – Still’s (or Not) with Daily…
View Resource
Not Still’s – Now What?
Your patient doesn’t meet criteria for Still’s disease (AOSD or sJIA), now what should…
View Resource